Wang Shuhong, Miao Jie, Qu Meijie, Yang Guo-Yuan, Shen Linhui
Department of Geriatrics, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200025, China.
Department of Geriatrics, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200025, China; Neuroscience and Neuroengineering Research Center, Med-X Research Institute and School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, 200030, China.
Biochem Biophys Res Commun. 2017 Nov 4;493(1):64-70. doi: 10.1016/j.bbrc.2017.09.073. Epub 2017 Sep 15.
Endothelial progenitor cells have been shown to differentiate into endothelial cells and to play a pivotal role in vascular homeostasis. Adiponectin has anti-atherogenic and anti-inflammatory properties via directly acting on vascular cells. The aim of the present study is to explore the effect of adiponectin on major functions involved in survival, migration, and tube formation of endothelial progenitor cells and to explore the underlying mechanism. In this study, we transferred adiponectin gene into endothelial progenitor cells via lentiviral vectors and investigated the proliferation, migration and tube formation of these transfected cells. We found that adiponectin is highly expressed in endothelial progenitor cells and promotes their proliferation, migration and tube formation. Western blot data showed that the former two processes were mediated through the AMPK/Akt/eNOS pathway, the latter via the AMPK/eNOS pathway. Use of the AMPK inhibitor (Compound C) or Akt inhibitor (MK-2206) reduced eNOS phosphorylation and attenuated adiponectin-induced endothelial progenitor cell proliferation, migration and tube formation compared to the controls (p < 0.05). Taken together, these data indicated that adiponectin promotes endothelial progenitor cell proliferation and migration via AMPK/Akt/eNOS signaling pathway and promotes tube formation through AMPK/eNOS, suggesting that adiponectin-transduced endothelial progenitor cell transplantation is a potential therapeutic target for vascular disease.
内皮祖细胞已被证明可分化为内皮细胞,并在血管稳态中发挥关键作用。脂联素通过直接作用于血管细胞而具有抗动脉粥样硬化和抗炎特性。本研究的目的是探讨脂联素对内皮祖细胞存活、迁移和管腔形成等主要功能的影响,并探究其潜在机制。在本研究中,我们通过慢病毒载体将脂联素基因导入内皮祖细胞,并研究这些转染细胞的增殖、迁移和管腔形成。我们发现脂联素在内皮祖细胞中高表达,并促进其增殖、迁移和管腔形成。蛋白质印迹数据表明,前两个过程是通过AMPK/Akt/eNOS信号通路介导的,后者是通过AMPK/eNOS信号通路介导的。与对照组相比,使用AMPK抑制剂(化合物C)或Akt抑制剂(MK-2206)可降低eNOS磷酸化水平,并减弱脂联素诱导的内皮祖细胞增殖、迁移和管腔形成(p<0.05)。综上所述,这些数据表明脂联素通过AMPK/Akt/eNOS信号通路促进内皮祖细胞增殖和迁移,并通过AMPK/eNOS促进管腔形成,提示脂联素转导的内皮祖细胞移植可能是血管疾病的一种潜在治疗靶点。